DCGI gives nod to Bharat Biotech to conduct phase I & II...

New Delhi [India], June 30 (ANI): The Drug Controller General of India (DCGI) has granted permission to Bharat...

Glenmark, Cipla stocks surge after nod to launch drugs for...

Mumbai (Maharashtra) [India], June 22 (ANI): Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to...

Anti-viral drug favipiravir gets DGCI nod for 'restricted...

New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral...

Remdesivir effective in treating critical COVID-19 patients,...

New Delhi [India], June 4 (ANI): Former honorary physician to the President of India and senior physician at...

COVID-19: Pharma giants seek DCGI's approval to manufacture,...

New Delhi [India], June 4 (ANI): Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached...

COVID-19: Remdesivir gets nod from CDCSO for 'restricted...

New Delhi [India], June 2 (ANI): In a significant development, the country's top drug controller the Central Drug...

Glenmark begins phase 3 of clinical trials on antiviral...

Mumbai (Maharashtra) [India], May 12 (ANI): Glenmark Pharmaceuticals has initiated phase three of clinical trials in...

CSIR to begin two clinical drug trials to combat COVID-19

New Delhi [India], May 8 (ANI): The Council for Scientific and Industrial Research (CSIR) has received approval from...

Zydus Cadila approaches DCGI to use hepatitis drug for...

New Delhi [India], May 5 (ANI): The country's top drug regulator, Drug Controller General of India (DCGI), has...

COVID-19: AIIMS Bhopal conducting multicentric study on...

Bhopal (Madhya Pradesh) [India], April 30 (ANI): A multicentric study on the use Mycobacterium w (Mw), heat-killed...

Glenmark to conduct clinical trials on Favipiravir anti-viral...

Mumbai (Maharashtra) [India], April 30 (ANI): Glenmark Pharmaceuticals said on Thursday it has received approval...

DCGI permits import of drug with residual shelf life less...

New Delhi [India], April 18 (ANI): In view of the COVID-19 pandemic, the country's top drug controller has granted...